We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRA
576
DELISTED
ProAssurance
PRA
| $25.1M | 0.03% |
1,039,901
+813,814
| +360% | +$19.6M |
|
577
Kaspi.kz JSC
KSPI
$17.9B
| $25M | 0.03% |
319,737
+189,157
| +145% | +$14.3M |
|
578
Arrowhead Research
ARWR
$12.5B
| $25M | 0.03% |
376,216
-416,750
| -53% | -$20.4M |
|
|
579
CALL
Alphabet (Google) Class A
GOOGL
$4.37T
| $24.9M | 0.03% |
79,700
-205,100
| -72% | -$58.6M |
|
580
Rithm Capital
RITM
$5.65B
| $24.8M | 0.03% |
2,276,797
-3,662,296
| -62% | -$40.5M |
|
581
PUT
JD.com
JD
$45.2B
| $24.8M | 0.03% |
863,800
+398,900
| +86% | +$12.5M |
|
582
PUT
Merck
MRK
$323B
| $24.7M | 0.03% |
234,700
+189,300
| +417% | +$17.8M |
|
583
Verastem
VSTM
$615M
| $24.7M | 0.03% |
3,195,726
-951,036
| -23% | -$8.48M |
|
584
Elanco Animal Health
ELAN
$11.1B
| $24.6M | 0.03% |
1,086,098
-964,189
| -47% | -$21M |
|
585
CALL
Uber
UBER
$159B
| $24.6M | 0.03% |
300,800
+54,700
| +22% | +$4.93M |
|
586
Suncor Energy
SU
$73.4B
| $24.5M | 0.03% |
551,974
-111,267
| -17% | -$4.7M |
|
587
WEC Energy
WEC
$34.6B
| $24.5M | 0.03% |
232,260
-716,103
| -76% | -$79.3M |
|
588
Pacira BioSciences
PCRX
$974M
| $24.5M | 0.03% |
945,979
-939,092
| -50% | -$22.3M |
|
589
Cardinal Health
CAH
$55.5B
| $24.4M | 0.03% |
118,923
+115,718
| +3,611% | +$21.8M |
|
|
SFD
590
Smithfield Foods
SFD
$9.62B
| $24.3M | 0.03% |
1,089,266
-575,319
| -35% | -$12.7M |
|
591
Teradyne
TER
$57.1B
| $24.2M | 0.03% |
124,973
-441,382
| -78% | -$75.7M |
|
592
CALL
Citigroup
C
$227B
| $24.1M | 0.03% |
206,600
+75,100
| +57% | +$7.8M |
|
593
PUT
Coinbase
COIN
$39.2B
| $24.1M | 0.03% |
106,500
-48,600
| -31% | -$14.5M |
|
|
CTLP
594
DELISTED
Cantaloupe
CTLP
| $24.1M | 0.03% |
2,265,943
+1,802,929
| +389% | +$19.1M |
|
595
Golar LNG
GLNG
$5.16B
| $24M | 0.03% |
643,662
+471,968
| +275% | +$18M |
|
596
Terreno Realty
TRNO
$7.45B
| $23.9M | 0.03% |
407,497
+342,740
| +529% | +$20.6M |
|
597
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $23.8M | 0.03% |
194,800
-61,200
| -24% | -$7.02M |
|
598
PUT
Eli Lilly
LLY
$1.1T
| $23.8M | 0.03% |
22,100
-5,400
| -20% | -$5.16M |
|
599
CALL
CrowdStrike
CRWD
$229B
| $23.7M | 0.03% |
202,000
+12,000
| +6% | +$1.53M |
|
600
Trane Technologies
TT
$105B
| $23.6M | 0.03% |
60,764
+59,976
| +7,611% | +$24.8M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.